Skip to main content
. Author manuscript; available in PMC: 2022 Feb 2.
Published in final edited form as: Science. 2021 Jul 20;373(6557):931–936. doi: 10.1126/science.abg5827

Figure 1. A drug repurposing screen identifies multiple safe-in-human drugs that inhibit OC43 infection.

Figure 1.

A. Schematic of the screen. A549 cells expressing H2B-mRuby were infected with OC43 (MOI 0.3), treated with drugs, incubated for 4 days at 33°C, and stained for the viral nucleoprotein. B. Screen results showing the %OC43 staining of mock-infected cells (green), no-drug controls (black), drugs with no effect on OC43 infection (blue), and screen hits (red). Overall agreement between the two repeats is high (R2=0.81) C. Dose response curves of remdesivir and the top hits from the screen, n = 3. Individual measurements are shown as semi-transparent circles (note that some circles overlap). Additional dose response curves are shown in Fig. S1.